Michael G. Stabin - Publications

Affiliations: 
Radiology and Radiological Sciences Vanderbilt University, Nashville, TN 

133 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Stabin MG, Wendt RE, Flux GD. RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals Part 1. Collection of Data for Radiopharmaceutical Dosimetry. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 34353875 DOI: 10.2967/jnumed.120.259200  0.397
2021 Stabin MG, Wendt RE, Flux GD. RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals Part 2. Data Analysis and Dosimetry. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 34353873 DOI: 10.2967/jnumed.121.262034  0.393
2021 Stabin M. Smith's "Internal Dose Calculation for Tc": An Excellent Paper with Approximate Methods. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 61: 30S-31S. PMID 33293449 DOI: 10.2967/jnumed.120.249938  0.306
2019 Stabin M. Comment on 'the role of radiation protection professionals in the landscape of low dose radiation'. Journal of Radiological Protection : Official Journal of the Society For Radiological Protection. 39: 1126-1127. PMID 31755417 DOI: 10.1088/1361-6498/ab2a81  0.349
2019 Zaidi H, Stabin MG, Madsen MT. Personalized dosimetry is a must for appropriate molecular radiotherapy. Medical Physics. PMID 31520420 DOI: 10.1002/Mp.13820  0.439
2019 Hope TA, Abbott A, Colucci K, Bushnell DL, Gardner L, Graham WS, Lindsay S, Metz DC, Pryma DA, Stabin MG, Strosberg JR. NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with Lu-DOTATATE. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 60: 937-943. PMID 31263080 DOI: 10.2967/Jnumed.118.230607  0.313
2019 Cicone F, Gnesin S, Denoël T, Stora T, van der Meulen NP, Müller C, Vermeulen C, Benešová M, Köster U, Johnston K, Amato E, Auditore L, Coukos G, Stabin M, Schaefer N, et al. Internal radiation dosimetry of a Tb-labeled antibody in tumor-bearing mice. Ejnmmi Research. 9: 53. PMID 31187358 DOI: 10.1186/S13550-019-0524-7  0.434
2018 Santos-Oliveira R, Stabin MG. Dose calculation of radioactive nanoparticles: first considerations for the Design of Theranostic Agents. Biomedical Microdevices. 20: 93. PMID 30374706 DOI: 10.1007/S10544-018-0338-9  0.308
2018 Stabin MG. New-Generation Fetal Dose Estimates for Radiopharmaceuticals. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 59: 1005-1006. PMID 29269568 DOI: 10.2967/jnumed.117.204214  0.327
2018 Stabin MG, Siegel JA. RADAR Dose Estimate Report: A Compendium of Radiopharmaceutical Dose Estimates Based on OLINDA/EXM Version 2.0. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 59: 154-160. PMID 28887400 DOI: 10.2967/Jnumed.117.196261  0.437
2017 Zanotti-Fregonara P, Stabin MG. New Fetal Radiation Doses for F-FDG Based on Human Data. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 58: 1865-1866. PMID 28572491 DOI: 10.2967/Jnumed.117.195404  0.388
2017 Stabin MG. Radiation dose and risks to fetus from nuclear medicine procedures. Physica Medica : Pm : An International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (Aifb). 43: 190-198. PMID 28454782 DOI: 10.1016/J.Ejmp.2017.04.001  0.493
2017 Carver DE, Kost SD, Fraser ND, Segars WP, Pickens DR, Price RR, Stabin MG. Realistic phantoms to characterize dosimetry in pediatric CT. Pediatric Radiology. PMID 28283725 DOI: 10.1007/S00247-017-3805-1  0.793
2016 Carver D, Kost S, Segars P, Fraser N, Pickens D, Price R, Stabin M. TH-AB-207A-06: The Use of Realistic Phantoms to Predict CT Dose to Pediatric Patients. Medical Physics. 43: 3860-3861. PMID 28047768 DOI: 10.1118/1.4958082  0.783
2016 Zanotti-Fregonara P, Chastan M, Edet-Sanson A, Ekmekcioglu O, Erdogan EB, Hapdey S, Hindie E, Stabin MG. New fetal doses from 18FDG administered during pregnancy: standardization of dose calculations and estimations with voxel-based anthropomorphic phantoms. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27261522 DOI: 10.2967/Jnumed.116.173294  0.494
2016 Zhang XM, Zhang HH, McLeroth P, Berkowitz RD, Mont MA, Stabin MG, Siegel BA, Alavi A, Barnett TM, Gelb J, Petit C, Spaltro J, Cho SY, Pomper MG, Conklin JJ, et al. [(124)I]FIAU: Human dosimetry and infection imaging in patients with suspected prosthetic joint infection. Nuclear Medicine and Biology. 43: 273-9. PMID 27150029 DOI: 10.1016/J.Nucmedbio.2016.01.004  0.321
2016 Gearhart A, Carver D, Stabin M. SU-F-I-79: Validation of a Monte Carlo Radiographic Simulation Medical Physics. 43: 3405-3405. DOI: 10.1118/1.4955907  0.79
2016 Yi Y, Stabin MG. Absorbed fractions and dose factors for a model of the mouse skeleton Nuclear Science and Techniques. 27. DOI: 10.1007/S41365-016-0005-X  0.437
2015 Siegel JA, Sacks B, Feinendegen LE, Welsh JS, Fornalski KW, Miller M, Mahn J, Gomez L, Stabin MG, Lewis P, Esposito VJ, Strupczewski A, Pennington CW, Cuttler JM, Rangacharyulu C, et al. Comment on "Background Ionizing Radiation and the Risk of Childhood Cancer: A Census-Based Nationwide Cohort Study". Environmental Health Perspectives. 123: A200. PMID 26230545 DOI: 10.1289/Ehp.1510111  0.371
2015 Stabin MG, Siegel JA. Radiation Dose and Hazard Assessment of Potential Contamination Events During Use of 223Ra Dichloride in Radionuclide Therapy. Health Physics. 109: 212-7. PMID 26222216 DOI: 10.1097/Hp.0000000000000310  0.481
2015 Stabin MG, Kost SD, Segars WP, Guilmette RA. Two Realistic Beagle Models for Dose Assessment. Health Physics. 109: 198-204. PMID 26222214 DOI: 10.1097/HP.0000000000000324  0.36
2015 Kost SD, Fraser ND, Carver DE, Pickens DR, Price RR, Hernanz-Schulman M, Stabin MG. Patient-specific dose calculations for pediatric CT of the chest, abdomen and pelvis. Pediatric Radiology. PMID 26142256 DOI: 10.1007/S00247-015-3400-2  0.798
2015 Liu T, Lin H, Xu X, Stabin M. WE-AB-204-11: Development of a Nuclear Medicine Dosimetry Module for the GPU-Based Monte Carlo Code ARCHER. Medical Physics. 42: 3661. PMID 26129187 DOI: 10.1118/1.4925887  0.372
2015 Mattsson S, Johansson L, Leide Svegborn S, Liniecki J, Noßke D, Riklund KÅ, Stabin M, Taylor D, Bolch W, Carlsson S, Eckerman K, Giussani A, Söderberg L, Valind S. Abstract. Annals of the Icrp. 44: 7-321. PMID 26069086 DOI: 10.1177/0146645314558019  0.499
2015 Carver DE, Kost SD, Fernald MJ, Lewis KG, Fraser ND, Pickens DR, Price RR, Stabin MG. Development and validation of a GEANT4 radiation transport code for CT dosimetry. Health Physics. 108: 419-28. PMID 25706135 DOI: 10.1097/Hp.0000000000000243  0.781
2015 Kost SD, Dewaraja YK, Abramson RG, Stabin MG. VIDA: a voxel-based dosimetry method for targeted radionuclide therapy using Geant4. Cancer Biotherapy & Radiopharmaceuticals. 30: 16-26. PMID 25594357 DOI: 10.1089/Cbr.2014.1713  0.516
2014 Stabin MG. Radiation dose concerns for the pregnant or lactating patient. Seminars in Nuclear Medicine. 44: 479-88. PMID 25362237 DOI: 10.1053/J.Semnuclmed.2014.06.003  0.42
2014 Zanzonico P, Stabin MG. Quantitative benefit-risk analysis of medical radiation exposures. Seminars in Nuclear Medicine. 44: 210-4. PMID 24832586 DOI: 10.1053/J.Semnuclmed.2014.03.010  0.354
2014 Fahey F, Stabin M. Dose optimization in nuclear medicine. Seminars in Nuclear Medicine. 44: 193-201. PMID 24832584 DOI: 10.1053/J.Semnuclmed.2014.03.006  0.482
2014 Stabin M, Xu XG. Basic principles in the radiation dosimetry of nuclear medicine. Seminars in Nuclear Medicine. 44: 162-71. PMID 24832580 DOI: 10.1053/J.Semnuclmed.2014.03.008  0.428
2014 Fahey FH, Stabin MG. In any use of ionizing radiation,consideration of the benefits of the exposures to possible risks is a central concern, for the physician and patient. Seminars in Nuclear Medicine. 44: 160-1. PMID 24832579 DOI: 10.1053/J.Semnuclmed.2014.03.002  0.359
2014 Joshi AD, Pontecorvo MJ, Adler L, Stabin MG, Skovronsky DM, Carpenter AP, Mintun MA. Radiation dosimetry of florbetapir F 18. Ejnmmi Research. 4: 4. PMID 24401181 DOI: 10.1186/2191-219X-4-4  0.515
2014 Carver D, Kost S, Pickens D, Price R, Stabin M. SU-F-18C-09: Assessment of OSL Dosimeter Technology in the Validation of a Monte Carlo Radiation Transport Code for CT Dosimetry Medical Physics. 41: 404-405. DOI: 10.1118/1.4889094  0.801
2013 Sydoff M, Lizana H, Mattsson S, Stabin MG, Leide-Svegborn S. Determination of the biodistribution and dosimetry of ¹²³I-FP-CIT in male patients with suspected Parkinsonism or Lewy body dementia using planar and combined planar and SPECT/CT imaging. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 82: 300-7. PMID 24135637 DOI: 10.1016/J.Apradiso.2013.09.006  0.43
2013 Yi Y, Stabin MG, McKaskle MH, Shone MD, Johnson AB. Comparison of measured and calculated dose rates near nuclear medicine patients. Health Physics. 105: 187-91. PMID 23799503 DOI: 10.1097/Hp.0B013E318290Cc0E  0.348
2013 Walker RC, Smith GT, Liu E, Moore B, Clanton J, Stabin M. Measured human dosimetry of 68Ga-DOTATATE. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 855-60. PMID 23516312 DOI: 10.2967/Jnumed.112.114165  0.322
2013 Stabin MG. INTERNAL DOSIMETRY IN NUCLEAR MEDICINE Brazilian Journal of Radiation Sciences. 1. DOI: 10.15392/Bjrs.V1I1.9  0.494
2012 Stabin MG, Xu XG, Emmons MA, Segars WP, Shi C, Fernald MJ. RADAR reference adult, pediatric, and pregnant female phantom series for internal and external dosimetry Journal of Nuclear Medicine. 53: 1807-1813. PMID 22967805 DOI: 10.2967/jnumed.112.106138  0.301
2012 Lin LL, Silvoniemi A, Stubbs JB, Rengan R, Suilamo S, Solin O, Divgi C, Eskola O, Sorger JM, Stabin MG, Kachur A, Hahn SM, Grönroos TJ, Forsback S, Evans SM, et al. Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients. Cancer Biotherapy & Radiopharmaceuticals. 27: 412-9. PMID 22897720 DOI: 10.1089/Cbr.2011.1130  0.427
2012 Doss M, Kolb HC, Zhang JJ, Bélanger MJ, Stubbs JB, Stabin MG, Hostetler ED, Alpaugh RK, von Mehren M, Walsh JC, Haka M, Mocharla VP, Yu JQ. Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 787-95. PMID 22499613 DOI: 10.2967/Jnumed.111.088955  0.351
2012 Arlicot N, Vercouillie J, Ribeiro MJ, Tauber C, Venel Y, Baulieu JL, Maia S, Corcia P, Stabin MG, Reynolds A, Kassiou M, Guilloteau D. Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation. Nuclear Medicine and Biology. 39: 570-8. PMID 22172392 DOI: 10.1016/J.Nucmedbio.2011.10.012  0.315
2012 Siegel JA, Stabin MG. Radar commentary: Use of linear no-threshold hypothesis in radiation protection regulation in the United States. Health Physics. 102: 90-9. PMID 22134084 DOI: 10.1097/Hp.0B013E318228E5B4  0.48
2012 Stabin MG, Emmons MA, Segars WP, Fernald MJ. Realistic reference adult and paediatric phantom series for internal and external dosimetry Radiation Protection Dosimetry. 149: 56-59. PMID 22128359 DOI: 10.1093/Rpd/Ncr383  0.411
2012 Varrone A, Gulyás B, Takano A, Stabin MG, Jonsson C, Halldin C. Simplified quantification and whole-body distribution of [18F]FE-PE2I in nonhuman primates: prediction for human studies. Nuclear Medicine and Biology. 39: 295-303. PMID 22033024 DOI: 10.1016/J.Nucmedbio.2011.08.004  0.359
2012 Carver D, Kost S, Clark J, Price R, Pickens D, Stabin M. SU-C-217A-04: Patient-Specific Dosimetry for CT Examinations in the Pediatric Population Medical Physics. 39: 3607-3607. DOI: 10.1118/1.4734646  0.553
2011 Varrone A, Stepanov V, Nakao R, Tóth M, Gulyás B, Emond P, Deloye JB, Vercouillie J, Stabin MG, Jonsson C, Guilloteau D, Halldin C. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1313-21. PMID 21764797 DOI: 10.2967/Jnumed.111.089953  0.386
2011 Lin YY, Chang CH, Li JJ, Stabin MG, Chang YJ, Chen LC, Lin MH, Tseng YL, Lin WJ, Lee TW, Ting G, Chang CA, Chen FD, Wang HE. Pharmacokinetics and dosimetry of (111)In/(188)Re-labeled PEGylated liposomal drugs in two colon carcinoma-bearing mouse models. Cancer Biotherapy & Radiopharmaceuticals. 26: 373-80. PMID 21711113 DOI: 10.1089/Cbr.2010.0906  0.317
2011 Takalkar AM, Khandelwal A, Lokitz S, Lilien DL, Stabin MG. 18F-FDG PET in pregnancy and fetal radiation dose estimates. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1035-40. PMID 21680687 DOI: 10.2967/Jnumed.110.085381  0.408
2011 de Carvalho AB, Stabin MG, Siegel JA, Hunt J. Comparison of point, line and volume dose calculations for exposure to nuclear medicine therapy patients. Health Physics. 100: 185-90. PMID 21399434 DOI: 10.1097/Hp.0B013E3181Eacf38  0.445
2011 Clark J, Stabin M, Pickens D, Price R. TH-A-214-01: Patient-Specific Dosimetry for Pediatric X-Ray Computed Tomography Medical Physics. 38: 3842-3842. DOI: 10.1118/1.3613466  0.569
2011 Mattsson S, Johansson L, Leide-Svegborn S, Liniecki J, Nosske D, Riklund K, Stabin M, Taylor D. Current activities in the ICRP concerning estimation of radiation doses to patients from radiopharmaceuticals for diagnostic use Journal of Physics: Conference Series. 317: 012008. DOI: 10.1088/1742-6596/317/1/012008  0.394
2010 Siegel JA, Stabin MG, Sharkey RM. Renal dosimetry: ready for biological equivalent dose? Response to medical internal radiation dose and European association of nuclear medicine committee letters. Cancer Biotherapy & Radiopharmaceuticals. 25: 763-5. PMID 21204773 DOI: 10.1089/Cbr.2010.0878  0.464
2010 Stabin MG. Proposed revision to the radiation dosimetry of 82Rb. Health Physics. 99: 811-3. PMID 21068600 DOI: 10.1097/Hp.0B013E3181E47B33  0.419
2010 Pereira JM, Stabin MG, Lima FRA, Guimarães MICC, Forrester JW. Image quantification for radiation dose calculations--limitations and uncertainties. Health Physics. 99: 688-701. PMID 20938240 DOI: 10.1097/Hp.0B013E3181E28Cdb  0.445
2010 Siegel JA, Stabin MG, Sharkey RM. Renal dosimetry: ready for biological effective dose? Cancer Biotherapy & Radiopharmaceuticals. 25: 589-91. PMID 20863249 DOI: 10.1089/Cbr.2010.0851  0.39
2010 Siegel JA, Stabin MG, Sharkey RM. Renal dosimetry in peptide radionuclide receptor therapy. Cancer Biotherapy & Radiopharmaceuticals. 25: 581-8. PMID 20849308 DOI: 10.1089/Cbr.2010.0805  0.43
2010 Clark LD, Stabin MG, Fernald MJ, Brill AB. Changes in radiation dose with variations in human anatomy: moderately and severely obese adults. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 929-32. PMID 20484429 DOI: 10.2967/Jnumed.109.073015  0.409
2010 Joyal JL, Barrett JA, Marquis JC, Chen J, Hillier SM, Maresca KP, Boyd M, Gage K, Nimmagadda S, Kronauge JF, Friebe M, Dinkelborg L, Stubbs JB, Stabin MG, Mairs R, et al. Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma. Cancer Research. 70: 4045-53. PMID 20442292 DOI: 10.1158/0008-5472.Can-09-4414  0.321
2010 Marine PM, Stabin MG, Fernald MJ, Brill AB. Changes in radiation dose with variations in human anatomy: larger and smaller normal-stature adults. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 806-811. PMID 20395339 DOI: 10.2967/Jnumed.109.073007  0.363
2010 Keenan MA, Stabin MG, Segars WP, Fernald MJ. RADAR realistic animal model series for dose assessment Journal of Nuclear Medicine. 51: 471-476. PMID 20197451 DOI: 10.2967/jnumed.109.070532  0.343
2010 Gulec SA, Sztejnberg ML, Siegel JA, Jevremovic T, Stabin M. Hepatic structural dosimetry in (90)Y microsphere treatment: a Monte Carlo modeling approach based on lobular microanatomy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 301-10. PMID 20080888 DOI: 10.2967/Jnumed.109.069278  0.485
2010 Mille M, Gu J, Ding A, Xu X, Stabin M, Liu B, Treves S, Fahey F. SU-GG-I-68: Calculation and Evaluation of Internal and External Radiation Exposure to Adult and Pediatric Patients from PET/CT Examinations Medical Physics. 37: 3117-3117. DOI: 10.1118/1.3468101  0.513
2010 Clark J, Pickens D, Stabin M, Price R. SU-GG-I-54: Patient-Specific Dosimetry for Pediatric X-Ray Computed Tomography Medical Physics. 37: 3114-3114. DOI: 10.1118/1.3468087  0.583
2009 Mettler FA, Bhargavan M, Faulkner K, Gilley DB, Gray JE, Ibbott GS, Lipoti JA, Mahesh M, McCrohan JL, Stabin MG, Thomadsen BR, Yoshizumi TT. Radiologic and nuclear medicine studies in the United States and worldwide: frequency, radiation dose, and comparison with other radiation sources--1950-2007. Radiology. 253: 520-31. PMID 19789227 DOI: 10.1148/Radiol.2532082010  0.423
2009 Stabin MG. Reply: Nuclear Medicine Radiation Risks Journal of Nuclear Medicine. 50: 489-489. DOI: 10.2967/Jnumed.108.058222  0.33
2008 Shi CY, Xu XG, Stabin MG. SAF values for internal photon emitters calculated for the RPI-P pregnant-female models using Monte Carlo methods. Medical Physics. 35: 3215-3224. PMID 28513010 DOI: 10.1118/1.2936414  0.33
2008 Stabin MG. Radiopharmaceuticals for nuclear cardiology: radiation dosimetry, uncertainties, and risk. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1555-63. PMID 18765586 DOI: 10.2967/Jnumed.108.052241  0.457
2008 Shi CY, Xu XG, Stabin MG. SAF values for internal photon emitters calculated for the RPI-P pregnant-female models using Monte Carlo methods. Medical Physics. 35: 3215-24. PMID 18697546 DOI: 10.1118/1.2936414  0.438
2008 Vicini P, Brill AB, Stabin MG, Rescigno A. Kinetic modeling in support of radionuclide dose assessment. Seminars in Nuclear Medicine. 38: 335-46. PMID 18662555 DOI: 10.1053/J.Semnuclmed.2008.05.007  0.38
2008 Stabin MG, Brill AB. State of the art in nuclear medicine dose assessment. Seminars in Nuclear Medicine. 38: 308-20. PMID 18662553 DOI: 10.1053/J.Semnuclmed.2008.05.005  0.483
2008 Stabin MG, Brill AB. Radiation dosimetry and exposure in nuclear medicine. Seminars in Nuclear Medicine. 38: 306-7. PMID 18662552 DOI: 10.1053/J.Semnuclmed.2008.05.009  0.361
2008 Stabin MG. Update: the case for patient-specific dosimetry in radionuclide therapy. Cancer Biotherapy & Radiopharmaceuticals. 23: 273-84. PMID 18593360 DOI: 10.1089/Cbr.2007.0445  0.435
2008 Stabin MG. Uncertainties in internal dose calculations for radiopharmaceuticals. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 853-60. PMID 18413398 DOI: 10.2967/Jnumed.107.048132  0.542
2008 Stabin MG. THE IMPORTANCE OF PATIENT-SPECIFIC DOSE CALCULATIONS IN NUCLEAR MEDICINE Nuclear Engineering and Technology. 40: 527-532. DOI: 10.5516/Net.2008.40.7.527  0.494
2007 Brown AK, Fujita M, Fujimura Y, Liow JS, Stabin M, Ryu YH, Imaizumi M, Hong J, Pike VW, Innis RB. Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28: a PET radioligand to image inflammation. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 2072-9. PMID 18006619 DOI: 10.2967/Jnumed.107.044842  0.395
2007 Willegaignon J, Guimarães MI, Stabin MG, Sapienza MT, Malvestiti LF, Marone MM, Sordi GM. Correction factors for more accurate estimates of exposure rates near radioactive patients: experimental, point, and line source models. Health Physics. 93: 678-88. PMID 17993848 DOI: 10.1097/01.Hp.0000275298.69543.5C  0.386
2007 Siegel JA, Marcus CS, Stabin MG. Licensee over-reliance on conservatisms in NRC guidance regarding the release of patients treated with 131I. Health Physics. 93: 667-77. PMID 17993847 DOI: 10.1097/01.Hp.0000270300.34270.44  0.388
2007 Traino AC, Ferrari M, Cremonesi M, Stabin MG. Influence of total-body mass on the scaling of S-factors for patient-specific, blood-based red-marrow dosimetry. Physics in Medicine and Biology. 52: 5231-48. PMID 17762083 DOI: 10.1088/0031-9155/52/17/009  0.391
2007 Siegel JA, Stabin MG. Mass scaling of S values for blood-based estimation of red marrow absorbed dose: The quest for an appropriate method Journal of Nuclear Medicine. 48: 253-256. PMID 17268023  0.39
2006 Willegaignon J, Guimarães MI, Sapienza MT, Stabin MG, Malvestiti LF, Marone M, Sordi GM. A new proposal for monitoring patients in nuclear medicine. Health Physics. 91: 624-9. PMID 17099406 DOI: 10.1097/01.Hp.0000225467.10064.34  0.384
2006 Waterhouse RN, Zhao J, Stabin MG, Ng H, Schindler-Horvat J, Chang RC, Mirsalis JC. Preclinical acute toxicity studies and dosimetry estimates of the novel sigma-1 receptor radiotracer, [18F]SFE. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 8: 284-91. PMID 16924428 DOI: 10.1007/S11307-006-0056-1  0.475
2006 Willegaignon J, Stabin MG, Guimarães MI, Malvestiti LF, Sapienza MT, Maroni M, Sordi GM. Evaluation of the potential absorbed doses from patients based on whole-body 131I clearance in thyroid cancer therapy. Health Physics. 91: 123-7. PMID 16832193 DOI: 10.1097/01.Hp.0000206041.25242.C0  0.449
2006 Brill AB, Stabin M, Bouville A, Ron E. Normal organ radiation dosimetry and associated uncertainties in nuclear medicine, with emphasis on iodine-131 Radiation Research. 166: 128-140. PMID 16808602 DOI: 10.1667/Rr3558.1  0.503
2006 Stabin M. Nuclear medicine dosimetry. Physics in Medicine and Biology. 51: R187-202. PMID 16790903 DOI: 10.1088/0031-9155/51/13/R12  0.466
2006 Newberg AB, Wintering NA, Plössl K, Hochold J, Stabin MG, Watson M, Skovronsky D, Clark CM, Kung MP, Kung HF. Safety, biodistribution, and dosimetry of 123I-IMPY: A novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease Journal of Nuclear Medicine. 47: 748-754. PMID 16644743  0.312
2006 Stabin MG, Peterson TE, Holburn GE, Emmons MA. Voxel-based mouse and rat models for internal dose calculations. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 655-9. PMID 16595500  0.403
2005 Thomas SR, Stabin MG, Castronovo FP. Radiation-absorbed dose from 201Tl-thallous chloride. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 502-8. PMID 15750165  0.364
2005 Dantas BM, Dantas ALA, Marques FLN, Bertelli L, Stabin MG. Determination of 99Mo contamination in a nuclear medicine patient submitted to a diagnostic procedure with 99mTc Brazilian Archives of Biology and Technology. 48: 215-220. DOI: 10.1590/S1516-89132005000700032  0.425
2004 Shi CY, Xu XG, Stabin MG. Specific absorbed fractions for internal photon emitters calculated for a tomographic model of a pregnant woman. Health Physics. 87: 507-11. PMID 15551788 DOI: 10.1097/01.Hp.0000133364.55155.09  0.47
2004 Wessels BW, Bolch WE, Bouchet LG, Breitz HB, Denardo GL, Meredith RF, Stabin MG, Sgouros G. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 45: 1725-33. PMID 15471841  0.308
2004 Belch A, McEwan* A, Hewitt* J, Riauka T, Stabin* M, Brill* A, Gallant G, Blake* L, Klein J. Tumor Targeting, Dosimetry and Clinical Response Data for Lymphorad-131 (LR131; Iodine I-131 Labeled B-Lymphocyte Stimulator) in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma. Blood. 104: 750-750. DOI: 10.1182/Blood.V104.11.750.750  0.459
2003 Stabin MG. Developments in the internal dosimetry of radiopharmaceuticals. Radiation Protection Dosimetry. 105: 575-80. PMID 14527030 DOI: 10.1093/OXFORDJOURNALS.RPD.A006306  0.44
2003 Stabin MG. Radiotherapy with internal emitters: what can dosimetrists offer? Cancer Biotherapy & Radiopharmaceuticals. 18: 611-7. PMID 14503957 DOI: 10.1089/108497803322287709  0.464
2003 Stabin MG, Siegel JA. Physical models and dose factors for use in internal dose assessment Health Physics. 85: 294-310. PMID 12938720 DOI: 10.1097/00004032-200309000-00006  0.507
2003 Waterhouse RN, Stabin MG, Page JG. Preclinical acute toxicity studies and rodent-based dosimetry estimates of the novel sigma-1 receptor radiotracer [(18)F]FPS. Nuclear Medicine and Biology. 30: 555-63. PMID 12831995 DOI: 10.1016/S0969-8051(03)00020-9  0.44
2003 Wiseman GA, Leigh BR, Dunn WL, Stabin MG, White CA. Additional radiation absorbed dose estimates for Zevalin radioimmunotherapy. Cancer Biotherapy & Radiopharmaceuticals. 18: 253-8. PMID 12804052 DOI: 10.1089/108497803765036436  0.51
2003 Breitz H, Wendt R, Stabin M, Bouchet L, Wessels B. Dosimetry of high dose skeletal targeted radiotherapy (STR) with 166Ho-DOTMP. Cancer Biotherapy & Radiopharmaceuticals. 18: 225-30. PMID 12804048 DOI: 10.1089/108497803765036391  0.495
2003 Siegel JA, Stabin MG, Sparks RB. Total-body and red marrow dose estimates Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 44: 320-321; author repl. PMID 12571225  0.341
2003 Siegel JA, Yeldell D, Goldenberg DM, Stabin MG, Sparks RB, Sharkey RM, Brenner A, Blumenthal RD. Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patients. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 44: 67-76. PMID 12515878  0.33
2002 Stabin MG, Siegel JA, Sparks RB. Sensitivity of model-based calculations of red marrow dosimetry to changes in patient-specific parameters Cancer Biotherapy and Radiopharmaceuticals. 17: 535-543. PMID 12470423 DOI: 10.1089/108497802760804763  0.467
2002 Stabin MG, Eckerman KF, Bolch WE, Bouchet LG, Patton PW. Evolution and status of bone and marrow dose models. Cancer Biotherapy & Radiopharmaceuticals. 17: 427-33. PMID 12396706 DOI: 10.1089/108497802760363213  0.35
2002 Stabin MG, da Luz LC. Decay data for internal and external dose assessment. Health Physics. 83: 471-5. PMID 12240721 DOI: 10.1097/00004032-200210000-00004  0.36
2002 Siegel JA, Stabin MG, Brill AB. The importance of patient-specific radiation dose calculations for the administration of radionuclides in therapy Cellular and Molecular Biology (Noisy-Le-Grand, France). 48: 451-459. PMID 12146697  0.325
2002 Hays MT, Watson EE, Thomas SR, Stabin M. MIRD dose estimate report no. 19: radiation absorbed dose estimates from (18)F-FDG. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 43: 210-4. PMID 11850487  0.39
2002 Stabin MG, Yoriyaz H. Photon specific absorbed fractions calculated in the trunk of an adult male voxel-based phantom. Health Physics. 82: 21-44. PMID 11768796 DOI: 10.1097/00004032-200201000-00005  0.425
2002 Stabin MG, Brill AB. Monoclonal antibodies in the treatment of hematologic malignancies: radiation dosimetry aspects. Current Pharmaceutical Biotechnology. 2: 351-6. PMID 11762416 DOI: 10.2174/1389201013378572  0.404
2002 Traino AC, Di Martino F, Lazzeri M, Stabin MG. Study of the correlation between administered activity and radiation committed dose to the thyroid in 131I therapy of Graves' disease. Radiation Protection Dosimetry. 95: 117-24. PMID 11572639 DOI: 10.1093/Oxfordjournals.Rpd.A006531  0.431
2000 Yoriyaz H, dos Santos A, Stabin MG, Cabezas R. Absorbed fractions in a voxel-based phantom calculated with the MCNP-4B code. Medical Physics. 27: 1555-62. PMID 10947258 DOI: 10.1118/1.599021  0.473
2000 Stabin MG. Internal dosimetry in the use of radiopharmaceuticals in therapy--science at a crossroads? Cancer Biotherapy & Radiopharmaceuticals. 14: 81-9. PMID 10850291 DOI: 10.1089/Cbr.1999.14.81  0.362
2000 Stabin MG, Konijnenberg M, Knapp FF, Spencer RH. Monte Carlo modeling of radiation dose distributions in intravascular radiation therapy. Medical Physics. 27: 1086-92. PMID 10841413 DOI: 10.1118/1.598973  0.488
2000 Toohey RE, Stabin MG, Watson EE. The AAPM/RSNA physics tutorial for residents: internal radiation dosimetry: principles and applications. Radiographics : a Review Publication of the Radiological Society of North America, Inc. 20: 533-46; quiz 531-2. PMID 10715348 DOI: 10.1148/Radiographics.20.2.G00Mc33533  0.507
2000 Traino AC, Di Martino F, Lazzeri M, Stabin MG. Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism. Physics in Medicine and Biology. 45: 121-9. PMID 10661587 DOI: 10.1088/0031-9155/45/1/309  0.419
2000 Eckerman KF, Stabin MG. Electron absorbed fractions and dose conversion factors for marrow and bone by skeletal regions. Health Physics. 78: 199-214. PMID 10647986 DOI: 10.1097/00004032-200002000-00009  0.404
2000 Cremonesi M, Ferrari M, Zoboli S, Chinol M, Trifirú G, Travaini L, Stabin MG, Maecke HR, Fiorenza M, Tosi G, Paganelli G. Biokinetics and dosimetry in patients administered with 111In-DOTA-Tyr3-Octreotide: Implications for internal radiotherapy with 90Y-DOTATOC Nuclear Medicine Communications. 21: 568-569. DOI: 10.1097/00006231-200006000-00037  0.35
1999 Knapp FF, Guhlke S, Beets AL, Lin WY, Stabin M, Amols H, Weinberger J. Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds. Cardiovascular Radiation Medicine. 1: 86-97. PMID 11272362 DOI: 10.1016/S1522-1865(98)00009-2  0.372
1999 Stabin MG, Tagesson M, Thomas SR, Ljungberg M, Strand SE. Radiation dosimetry in nuclear medicine Applied Radiation and Isotopes. 50: 73-87. PMID 10028629 DOI: 10.1016/S0969-8043(98)00023-2  0.525
1999 Cremonesi M, Ferrari M, Chinol M, Stabin MG, Grana C, Prisco G, Robertson C, Tosi G, Paganelli G. Three-step radioimmunotherapy with yttrium-90 biotin: Dosimetry and pharmacokinetics in cancer patients European Journal of Nuclear Medicine and Molecular Imaging. 26: 110-120. PMID 9933344 DOI: 10.1007/S002590050366  0.44
1999 Stabin M, Brill A, Yoriyaz H. 10. Status of internal dose calculations for radiolabeled antibodies and other therapeutic agents Nuclear Medicine Communications. 20: 950-951. DOI: 10.1097/00006231-199910000-00053  0.4
1998 Stabin MG. Health concerns related to radiation exposure of the female nuclear medicine patient. Environmental Health Perspectives. 1403-9. PMID 9467052 DOI: 10.1289/Ehp.97105S61403  0.456
1998 Rijks LJ, Busemann Sokole E, Stabin MG, de Bruin K, Janssen AG, van Royen EA. Biodistribution and dosimetry of iodine-123-labelled Z-MIVE: an oestrogen receptor radioligand for breast cancer imaging. European Journal of Nuclear Medicine. 25: 40-7. PMID 9396873 DOI: 10.1007/S002590050192  0.394
1998 Booij J, Busemann Sokole E, Stabin MG, Janssen AG, de Bruin K, van Royen EA. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters. European Journal of Nuclear Medicine. 25: 24-30. PMID 9396871 DOI: 10.1007/S002590050190  0.429
1998 Stabin M. Dosimetry of External Beta Rays for Radiation Protection Radiation Research. 149: 107. DOI: 10.2307/3579688  0.31
1997 Russell JR, Stabin MG, Sparks RB, Watson E. Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals Health Physics. 73: 756-769. PMID 9378651 DOI: 10.1097/00004032-199711000-00003  0.512
1997 Russell JR, Stabin MG, Sparks RB. Placental transfer of radiopharmaceuticals and dosimetry in pregnancy Health Physics. 73: 747-755. PMID 9378650 DOI: 10.1097/00004032-199711000-00002  0.452
1997 Zalutsky MR, Stabin MG, Larsen RH, Bigner DD. Tissue distribution and radiation dosimetry of astatine-211-labeled chimeric 81C6, an alpha-particle-emitting immunoconjugate. Nuclear Medicine and Biology. 24: 255-61. PMID 9228660 DOI: 10.1016/S0969-8051(97)00060-7  0.329
1997 Stabin MG, Stubbs JB, Russell JR. Review of the fetal radiation doses received from 59Fe kinetic studies at Vanderbilt University in the 1940's Health Physics. 72: 701-707. PMID 9106710 DOI: 10.1097/00004032-199705000-00004  0.481
1995 Evans JF, Stabin MG, Stubbs JB. Specific absorbed fractions of energy from internal photon sources in brain tumor and cerebrospinal fluid. Medical Physics. 22: 331-40. PMID 7596323 DOI: 10.1118/1.597448  0.403
1993 Stabin M, Stubbs J, Watson E. Recent controversy in radiation dosimetry. European Journal of Nuclear Medicine and Molecular Imaging. 20: 371-372. PMID 8519254 DOI: 10.1007/Bf00208993  0.527
1993 Verhoeff NP, Sokole EB, Stabin M, Hengst D, Kung HF, Van Royen EA, Janssen AG. Dosimetry of iodine-123 iodobenzamide in healthy volunteers. European Journal of Nuclear Medicine. 20: 747-52. PMID 8223767 DOI: 10.1007/Bf00180903  0.482
1991 Washburn LC, Sun TT, Lee YC, Byrd BL, Holloway EC, Crook JE, Stubbs JB, Stabin MG, Brechbiel MW, Gansow OA. Comparison of five bifunctional chelate techniques for 90Y-labeled monoclonal antibody CO17-1A. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 18: 313-21. PMID 2071444 DOI: 10.1016/0883-2897(91)90127-7  0.326
1988 Marcus CS, Stabin MG, Watson EE, Henneman PL, Butler JA, Kuperus JH. Dosimetry of leukocytes labeled with 99Tcm-albumin colloid. Nuclear Medicine Communications. 9: 249-54. PMID 3386981 DOI: 10.1097/00006231-198803000-00009  0.396
1988 Washburn LC, Lee YC, Sun TT, Byrd B, Crook JE, Stabin MG, Steplewski Z. Preclinical assessment of 90Y-labeled monoclonal antibody CO17-1A, a potential agent for radioimmunotherapy of colorectal carcinoma. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 15: 707-11. PMID 3251904 DOI: 10.1016/0883-2897(88)90065-7  0.332
1983 Watson EE, Stabin MG. BASIC ALTERNATIVE SOFTWARE PACKAGE FOR INTERNAL RADIATION DOSE CALCULATIONS Clinical Nuclear Medicine. 8: P62. DOI: 10.1097/00003072-198310001-00033  0.478
Show low-probability matches.